Funding Briefs

For Would-Be Biotechnologists The demand for biotechnologists is growing faster than the supply, according to the National Institute of General Medical Sciences (NIGMS). As a result, the institute has created a new program: Biotechnology Research Training grants. NIGMS will fund an institutional training program as well as individual predoctoral, postdoctoral, and senior fellowships. These provide an annual stipend ranging from $8,500 to $31,500 for three- to five-year projects that apply engi

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The demand for biotechnologists is growing faster than the supply, according to the National Institute of General Medical Sciences (NIGMS). As a result, the institute has created a new program: Biotechnology Research Training grants. NIGMS will fund an institutional training program as well as individual predoctoral, postdoctoral, and senior fellowships. These provide an annual stipend ranging from $8,500 to $31,500 for three- to five-year projects that apply engineering, physics, chemistry, mathematics, and biology to biotechnology-related medical research. Applicants are encouraged to discuss their plans with NIGMS before writing a proposal. Deadlines for 1989: January 10, May 10, and September 10.

(Contact: Luther S. Williams, NIGMS, 301-496-0186.)

Among the variety of programs aimed at encouraging minority students to choose science careers, the latest is a program to boost the failing fortunes of an unlikely minority indeed: the U.S. citizen. The brightest U.S. students often end up in business, medical, or law ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies